Insider Trading May 22, 2026 04:43 PM

Lumentum Director Sells Stock After Significant Gains; Company Improves Financial Metrics

Ian Small disposes of shares valued at $4.3 million, following reports of strong earnings and Nasdaq-100 inclusion.

By Marcus Reed LITE

Director Ian Small sold Lumentum Holdings Inc. stock valued at approximately $4.3 million on May 21, 2026. This transaction occurred amidst positive company news, including Q3 FY2026 earnings that beat expectations and the impending addition of LITE to the Nasdaq-100 Index. The sale was structured as a contribution to an exchange fund.

Lumentum Director Sells Stock After Significant Gains; Company Improves Financial Metrics
LITE

Key Points

  • Lumentum reported Q3 FY2026 earnings that beat expectations, achieving an EPS of $2.37 against a forecast of $2.26.
  • The company is scheduled for inclusion in the Nasdaq-100 Index on May 18, 2026, which tracks major non-financial companies.
  • BofA Securities raised its price target to $1,100 and increased earnings estimates for both FY2026 ($13.80 EPS) and FY2027 ($22 EPS).

Ian Small, who serves as a director at Lumentum Holdings Inc., executed a transaction on May 21, 2026, involving the disposal of company common stock valued near $4.3 million.

Specifically, Mr. Small divested 4,954 shares of Lumentum common stock. These shares were calculated to be worth $868.07 per share, totaling a transaction value of $4,300,418. It is noteworthy that the current market price for the stock has since risen considerably to $946.90, reflecting a substantial 1,171% return over the past year.

The filing details further context regarding valuation and potential investor sentiment. According to an analysis from InvestingPro Fair Value, the stock is currently assessed as appearing overvalued at its present levels, placing it on the Most Overvalued list. This assessment is available alongside a comprehensive Pro Research Report detailing LITE’s investment prospects.


Structure of the Transaction

A footnote within the official filing clarified that the shares were contributed to an exchange fund. As compensation for this contribution, Mr. Small is scheduled to receive shares in the exchange fund at a subsequent date. This future receipt is projected to occur no sooner than seven years after the initial transfer date.

For the purpose of calculating the exchange value, the common stock was valued at $868.07. This specific valuation represented the closing price observed on The Nasdaq Global Select Market on May 20, 2026, which was the business day immediately preceding the transaction.

It is important to note that following this disposal, Mr. Small relinquished voting control over these transferred shares. Furthermore, he does not exert influence over the investment decisions made by either the exchange fund or the shares he will ultimately receive through the arrangement.


Company Performance and Market Developments

Beyond the director's activity, Lumentum Holdings Inc. recently reported its Q3 for Fiscal Year 2026 earnings. These results showed performance exceeding what analysts had projected. The company achieved an earnings per share (EPS) of $2.37, surpassing the forecasted figure of $2.26. Revenue also performed well, reaching $808.4 million, which was slightly higher than the anticipated revenue of $802.94 million.

Further cementing its market standing, Lumentum is slated to be included in the Nasdaq-100 Index before the market opens on May 18, 2026. This inclusion holds significance because the Nasdaq-100 Index tracks the largest non-financial companies listed on the Nasdaq exchange.


Analyst Coverage and Market Positioning

In other recent developments, BofA Securities updated its price target for Lumentum to $1,100, an increase from a previous target of $775. The bank cited a positive margin outlook when making this adjustment, while simultaneously maintaining a Neutral rating on the company's shares. Additionally, BofA Securities boosted its earnings estimates for two future fiscal periods: 2026 and 2027. For FY2026, they projected an EPS of $13.80, and for FY2027, they projected an EPS of $22.

These various developments, spanning strong financial reporting, index inclusion, and positive analyst revisions, collectively reflect the company's sustained robust financial performance and its strategic standing within the broader market landscape.

Risks

  • The stock's current valuation is flagged by InvestingPro Fair Value as 'Most Overvalued,' suggesting potential market overextension.
  • A director's sale of shares, even if structured for an exchange fund, can influence perceptions of internal confidence or liquidity needs within the company.
  • The analyst rating from BofA Securities remains at 'Neutral,' despite raising price targets and increasing earnings estimates.

More from Insider Trading

Horizon Kinetics Adds $406 Stake in Texas Pacific Land Corp Amid Stock Surge Jun 4, 2026 RCG Fund Insider Activity: Co-Portfolio Manager Peter Doyle Acquires Additional RCG Shares Jun 4, 2026 FMAO Director Andrew J. Briggs Executes $82K Stock Sale Under Pre-Arranged Plan Jun 4, 2026 Global Innovative Platforms Insider: David Brown Accumulates $202,000 in Stock Jun 4, 2026 Itron SVP John Marcolini Executes $946,085 Share Sale Under Pre-Arranged Plan Jun 4, 2026